Efficacy and safety of poly ADP-ribose polymerase inhibitors (PARPis) in extensive-stage small-cell lung cancer (ES-SCLC) treatment: a systematic review and meta-analysis. [PDF]
Cheng CC +11 more
europepmc +1 more source
Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors. [PDF]
O'Sullivan Coyne G +19 more
europepmc +1 more source
Real-World Germline BRCA Testing, Poly(ADP-ribose) Polymerase Inhibitor Utilization, and Survival Outcomes in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. [PDF]
Yadav S +8 more
europepmc +1 more source
Clinical evaluation of combined programmed cell death protein 1 inhibitor and poly(ADP-ribose) polymerase inhibitor in metastatic castration-resistant prostate cancer patients: Insights from a real-world study. [PDF]
Shao Y +9 more
europepmc +1 more source
Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations. [PDF]
Turaga SM +9 more
europepmc +1 more source
Novel clinical potential of poly (ADP‑ribose) polymerase inhibitors in triple‑negative breast cancer: Mechanistic insights and clinical applications (Review). [PDF]
Han Y, Wei L.
europepmc +1 more source
Antioxidant Defenses and Poly(ADP-Ribose) Polymerase (PARP) Activity Provide "Radioresilience" Against Ionizing Radiation-Induced Stress in Dwarf Bean Plants. [PDF]
Hay Mele B +5 more
europepmc +1 more source
Next-Generation Sequencing-Guided Treatment of BRCA2-Mutant Metastatic Uterine Leiomyosarcoma With Poly(ADP-ribose) Polymerase Inhibitor Therapy. [PDF]
Kirkendoll C, Mansour R, Gaddam SJ.
europepmc +1 more source

